0001752724-23-236096.txt : 20231025 0001752724-23-236096.hdr.sgml : 20231025 20231025081022 ACCESSION NUMBER: 0001752724-23-236096 CONFORMED SUBMISSION TYPE: N-CEN/A PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20210831 FILED AS OF DATE: 20231025 DATE AS OF CHANGE: 20231025 EFFECTIVENESS DATE: 20231025 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PIONEER SERIES TRUST X CENTRAL INDEX KEY: 0001174520 IRS NUMBER: 030460956 FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: N-CEN/A SEC ACT: 1940 Act SEC FILE NUMBER: 811-21108 FILM NUMBER: 231344052 BUSINESS ADDRESS: STREET 1: 60 STATE STREET STREET 2: 5TH FLOOR CITY: BOSTON STATE: MA ZIP: 02109 BUSINESS PHONE: 617-742-7825 MAIL ADDRESS: STREET 1: 60 STATE STREET STREET 2: 5TH FLOOR CITY: BOSTON STATE: MA ZIP: 02109 FORMER COMPANY: FORMER CONFORMED NAME: PIONEER FUNDAMENTAL GROWTH FUND DATE OF NAME CHANGE: 20051213 FORMER COMPANY: FORMER CONFORMED NAME: PIONEER LARGE CAP GROWTH FUND DATE OF NAME CHANGE: 20020530 0001174520 S000031914 Pioneer Corporate High Yield Fund C000099381 Pioneer Corporate High Yield Fund: Class A RCRAX C000099382 Pioneer Corporate High Yield Fund: Class C RCRCX C000099383 Pioneer Corporate High Yield Fund: Class Y RCRYX N-CEN/A 1 primary_doc.xml X0404 N-CEN/A LIVE 0001174520 XXXXXXXX 811-21108 true false false N-1A S000031914 C000099383 C000099381 C000099382 Pioneer Series Trust X 811-21108 0001174520 549300OT70Y6XDA91822 60 State Street Boston 02109-1820 US-MA US 617-422-4947 Brown Brothers Harriman & Co. 50 Post Office Sq. Boston 02110-1543 617-772-1818 Books and records N N N-1A 3 Y MARGUERITE A. PIRET N/A N KENNETH J. TAUBES N/A Y THOMAS J. PERNA N/A N DIANE DURNIN 004798101 N LISA M. JONES N/A Y CRAIG C. MACKAY 002008771 N JOHN E. BAUMGARDNER, JR. N/A N BENJAMIN M. FRIEDMAN N/A N FRED J. RICCIARDI N/A N LORRAINE H. MONCHAK N/A N John M. Malone 002314031 60 State Street Boston 02109-1820 XXXXXX N N N N N N N Amundi Distributor US, Inc. 8-41256 000024497 549300OSI141GCUW7776 Y N ERNST & YOUNG LLP 42 254900H1VLSDPE6LJK37 N N N N N N N Pioneer Corporate High Yield Fund S000031914 HNEH6BRMRL0UD63MV889 N 4 0 0 N/A N N N N N/A N/A N/A Rule 32a-4 (17 CFR 270.32a-4) Rule 10f-3 (17 CFR 270.10f-3) Rule 17a-8 (17 CFR 270.17a-8) Rule 22d-1 (17 CFR 270.22d-1) Rule 17a-7 (17 CFR 270.17a-7) Y Y N N Amundi Asset Management US, Inc. 028-04037 000107719 GVETZ2DEF39OCQ4SSX41 N DST Asset Manager Solutions, Inc. 084-00896 N/A N N N Intercontinental Exchange, Inc. 5493000F4ZO33MV32P92 N Refinitiv US LLC 213800HQORQAP68CJJ04 N Bear Stearns 549300L8HTN2UIEXSQ93 N N CITIBANK, N.A.- CAIRO BRANCH E57ODZWZ7FF32TWEFA76 EG N N Foreign custodian - rule 17f-5 (17 CFR 270.17f-5) BANCO ITAU URUGUAY S.A. FOR BANCO ITAU URUGUAY S.A. AND ITAU UNIBANCO S.A. 549300HU8OQS1VTVXN55 UY N N Foreign custodian - rule 17f-5 (17 CFR 270.17f-5) BROWN BROTHERS HARRIMAN & CO. 5493006KMX1VFTPYPW14 N N Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1)) EUROCLEAR BANK SA NV 549300OZ46BRLZ8Y6F65 BE N Y Foreign securities depository - rule 17f-7 (17 CFR 270.17f-7) Y DST Asset Manager Solutions, Inc. 84-00896 SEC File number N N N Brown Brothers Harriman & Co. 5493006KMX1VFTPYPW14 N Y Amundi Asset Management US, Inc. GVETZ2DEF39OCQ4SSX41 Y N N Amundi Distributor US, Inc. 008-41256 000024497 549300OSI141GCUW7776 0.00000000 Credit Agricole Securities (USA) Inc. 008-13753 000000190 549300WO2DKF0Q3YMV43 0.00000000 J.P. MORGAN SECURITIES LLC 008-35008 000000079 ZBUT11V806EZRVTWT807 26.39000000 26.39000000 Goldman Sachs & Co, LLC 008-00129 000000361 FOR8UP27PHTHYVLBNG30 12727217.00000000 MORGAN STANLEY & CO. LLC 008-15869 000008209 9R7GPTSO7KV3UQJZQ078 7624700.00000000 ROYAL BANK OF CANADA N/A 000031194 ES7IP3U3RHIGC71XBU11 CA 11541924.00000000 BARCLAYS CAPITAL INC. 008-41342 000019714 AC28XWWI3WIBK2824319 7875150.00000000 MERRILL LYNCH, PIERCE, FENNER & SMITH INC. 008-07221 000007691 8NAV47T0Y26Q87Y0QP81 18376971.00000000 Citigroup Global Markets Inc. 008-08177 000007059 MBNUM2BPBDO7JBLYG310 38076187.00000000 CREDIT SUISSE SECURITIES (USA) LLC 008-00422 000000816 1V8Y6QCX6YMJ2OELII46 18479101.00000000 BNY MELLON CAPITAL MARKETS, LLC 008-35255 000017454 VJW2DOOHGDT6PR0ZRO63 15076168.00000000 J.P. MORGAN SECURITIES LLC 008-35008 000000079 ZBUT11V806EZRVTWT807 206348977.00000000 Jefferies LLC 008-15074 000002347 58PU97L1C0WSRCWADL48 9221402.00000000 366492368.00000000 Y 80623587.14000000 Committed 450000000.00000000 N N N N false false true false false true INTERNAL CONTROL RPT 2 seriestrustx_ex1.htm

Report of Independent Registered Public Accounting Firm

 

To the Shareholders and Board of Trustees of

Pioneer Series Trust X:

 

In planning and performing our audit of the financial statements of Pioneer Corporate High Yield Fund (the “Fund”) (one of the funds constituting Pioneer Series Trust X) as of and for the year ended August 31, 2021, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), we considered the Fund’s internal control over financial reporting, including controls over safeguarding securities, as a basis for designing our auditing procedures for the purpose of expressing our opinion on the financial statements and to comply with the requirements of Form N-CEN, but not for the purpose of expressing an opinion on the effectiveness of the Fund’s internal control over financial reporting. Accordingly, we express no such opinion.


The management of the Fund is responsible for establishing and maintaining effective internal control over financial reporting. In fulfilling this responsibility, estimates and judgments by management are required to assess the expected benefits and related costs of controls. A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with U.S. generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with U.S. generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of a company’s assets that could have a material effect on the financial statements.

 

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

 

A deficiency in internal control over financial reporting exists when the design or operation of a control does not allow management or employees, in the normal course of performing their assigned functions, to prevent or detect misstatements on a timely basis. A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the company’s annual or interim financial statements will not be prevented or detected on a timely basis.

 

Our consideration of the Fund’s internal control over financial reporting was for the limited purpose described in the first paragraph and would not necessarily disclose all deficiencies in internal control that might be material weaknesses under standards established by the PCAOB. However, we noted no

deficiencies in the Fund’s internal control over financial reporting and its operation, including controls over safeguarding securities that we consider to be a material weakness as defined above as of August 31, 2021.

 

This report is intended solely for the information and use of management and the Board of Trustees of Pioneer Series Trust X, and the Securities and Exchange Commission and is not intended to be and should not be used by anyone other than these specified parties.

 

 

/s/ ERNST & YOUNG LLP

 

Boston, Massachusetts

November 4, 2021

 

OTHER REQUIRED INFO 3 explanatory_note_2023.htm

Form: N-CEN/A

Explanation:

This amendment is being filed to address incorrect or omitted responses from the original submission.